Showing results (2141-2150 of 2,395) with videos related to

Sort By:
Pageof 240
Pediatric Cardiology|November 18, 2017
Risk Factors for Development of Ectopic Atrial Tachycardia in Post-operative Congenital Heart DiseaseBradley C Clark, John T Berger, Charles I Berul, et al.
Cancer Letters|October 29, 2000
The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant cryptsA T Baines, H Holubec, J L Basye, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2006
Comparison of lorazepam [7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one] occupancy of rat brain gamma-aminobutyric acid(A) receptors measured using in vivo [3H]flumazenil (8-fluoro 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester) binding and [11C]flumazenil micro-positron emission tomographyJohn R Atack, Paul Scott-Stevens, John S Beech, et al.
Science (New York, N.Y.)|June 19, 2004
Surface of young Jupiter family comet 81P/Wild 2: view from the Stardust SpacecraftDonald E Brownlee, Friedrich Horz, Ray L Newburn, et al.
Nano Letters|December 18, 2019
NanoMEA: A Tool for High-Throughput, Electrophysiological Phenotyping of Patterned Excitable CellsAlec S T Smith, Eunpyo Choi, Kevin Gray, et al.
Nature Genetics|September 1, 1992
Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic miceJ A Whitsett, C R Dey, B R Stripp, et al.
American Journal of Preventive Medicine|October 24, 2008
Fidelity versus flexibility: translating evidence-based research into practiceDeborah J Cohen, Benjamin F Crabtree, Rebecca S Etz, et al.
Blood Advances|November 14, 2022
Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibitionPhilippe Billiald, Alexandre Slater, Martin Welin, et al.
Stroke|August 30, 2003
Assessment of cerebrovascular autoregulation in head-injured patients: a validation studyLuzius A Steiner, Jonathan P Coles, Andrew J Johnston, et al.
British Journal of Urology|June 20, 1998
Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trialL C Clark, B Dalkin, A Krongrad, et al.
Pageof 240